What is the difference between Aleminib and Baricitinib? Analysis of functions and indications

Baricitinib (trade name: Alemin) is an oral JAK inhibitor, mainly used to treat moderate to severe active rheumatoid arthritis, systemic lupus erythematosus, atopic dermatitis and other autoimmune diseases. Its mechanism is to inhibit the JAK1 and JAK2 signaling pathways, thereby blocking the signal transduction of multiple inflammatory factors to achieve anti-inflammatory and immunoregulatory effects. Baricitinib itself is the generic name of the drug, and "Alemin" is one of the trade names. The two are essentially the same drug, and there is no difference in active ingredients.

Althoughthe name "Alemin Baricitinib" looks like a combination of two different drugs, in fact it still refers to Baricitinib, which is just a superposition of the trade name and generic name. For example, in mainland China, Ailemin is one of the trade names of baricitinib, which is jointly launched by Eli Lilly and Illumina. Therefore, it is the same drug as "baricitinib", but there are differences in sales and brand naming.

In terms of indications, baricitinib was initially approved for the treatment of patients with rheumatoid arthritis who have had an inadequate response to one or more antirheumatic drugs. With the deepening of research, it has also been used to treat immune-related diseases such as systemic lupus erythematosus and atopic dermatitis. In addition, during the COVID-19 epidemic, baricitinib was also approved for use in combination with remdesivir to treat severe COVID-19 patients who require oxygen support, indicating its broad application potential in a variety of inflammation-related diseases.

To sum up, aleminib and baricitinib are essentially the same drugs, with only different names. It is a potent JAK1/2 inhibitor and is suitable for the treatment of a variety of inflammatory and autoimmune diseases. Patients should follow the doctor's guidance during use, choose a dose reasonably according to the type and severity of the disease, and monitor blood routine, liver function and other indicators to ensure safe and effective use of the drug.

Reference materials:https://www.mims.com/hongkong/drug/info/baricitinib?mtype=generic